ENDRA Life Sciences (NDRA) Current Assets: 2016-2021
Historic Current Assets for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $14.5 million.
- ENDRA Life Sciences' Current Assets rose 202.75% to $14.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $14.5 million, marking a year-over-year increase of 202.75%. This contributed to the annual value of $8.2 million for FY2020, which is 25.59% up from last year.
- As of Q3 2021, ENDRA Life Sciences' Current Assets stood at $14.5 million, which was down 11.46% from $16.3 million recorded in Q2 2021.
- ENDRA Life Sciences' Current Assets' 5-year high stood at $18.4 million during Q1 2021, with a 5-year trough of $265,648 in Q1 2017.
- Over the past 3 years, ENDRA Life Sciences' median Current Assets value was $4.8 million (recorded in 2020), while the average stood at $7.7 million.
- Per our database at Business Quant, ENDRA Life Sciences' Current Assets surged by 2,907.34% in 2017 and then plummeted by 86.17% in 2018.
- ENDRA Life Sciences' Current Assets (Quarterly) stood at $5.9 million in 2017, then climbed by 18.15% to $6.9 million in 2018, then dropped by 5.96% to $6.5 million in 2019, then grew by 25.59% to $8.2 million in 2020, then surged by 202.75% to $14.5 million in 2021.
- Its last three reported values are $14.5 million in Q3 2021, $16.3 million for Q2 2021, and $18.4 million during Q1 2021.